Enhanced Synthesis and Delivery of Magnesium Oxide Nanoparticles for Reverse Insulin Resistance in Type 2 Diabetes Mellitus
Access Status
Open access
Authors
Jeevanandam, Jaison
Date
2017Supervisor
Prof. Michael Danquah
Type
Thesis
Award
PhD
Metadata
Show full item recordFaculty
Curtin Sarawak
Collection
Abstract
Type 2 diabetes has emerged to be a major threat to human health. The current study focuses on the formulation of a potential drug to reverse insulin resistance in adipose cells in order to enhance glucose uptake. As magnesium deficiency has proven to increase insulin resistance in diabetic patients, a formulation of magnesium oxide nanoparticles is proposed and proved as a potential drug for reversing insulin resistance and in treating type 2 diabetes.
Related items
Showing items related by title, author, creator and subject.
-
O'Gorman, D.; Yousif, O.; Dixon, G.; McQuaid, S.; Murphy, E.; Rahman, Y.; Gasparro, D.; Pacini, G.; Newsholme, Philip; Nolan, J. (2008)The purpose of this study was to determine if immune mechanisms in GAD positive patients' contribute to the pathogenesis of a specific sub-type of Type 2 diabetes. GAD positive (n = 8) and GAD negative (n = 8) subjects ...
-
Carnagarin, R.; Dharmarajan, Arunasalam; Dass, Crispin (2015)Pigment epithelium-derived factor (PEDF) is an anti-angiogenic serpin associated with insulin resistance in metabolic disorders such as diabetes, metabolic syndrome, obesity and polycystic ovarian syndrome. While the ...
-
Newsholme, Philip; De Bittencourt, P.; O'Hagan, C.; De Vito, G.; Murphy, C.; Krause, M. (2010)It is now widely accepted that hypertension and endothelial dysfunction are associated with an insulin-resistant state and thus with the development of T2DM (Type 2 diabetes mellitus). Insulin signalling is impaired in ...